The European Union has warned it will tighten rules on exports of Covid vaccines, amid a row with AstraZeneca over a cut in planned supplies to the 27-member bloc. Health Commissioner Stella Kyriakides said the EU will take any action required to protect its citizens.
Brazil approved two vaccines for emergency use against the coronavirus on Sunday as the country’s death toll from the disease it causes neared 210,000 and some of its hospitals grappled with an oxygen shortage.
The Falkland Islands Government informed on Tuesday in a Press Release that it is “pleased” to announce that 3,000 doses of the Oxford-AstraZeneca vaccine are expected to be received in the first week of February 2021.
Brazil made a diplomatic push on Monday to guarantee an Indian-made shipment of British drugmaker AstraZeneca's COVID-19 vaccine, hoping to avoid export restrictions that could delay immunizations during the world's second-deadliest outbreak.
British Prime Minister Boris Johnson on Monday ordered England into a new national lockdown to contain a surge in COVID-19 cases that threatens to overwhelm parts of the health system before a vaccine program reaches a critical mass.
Brazil's health regulator Anvisa said over the weekend it had approved the import of 2 million doses of the COVID-19 vaccine developed by AstraZeneca and the University of Oxford, although the jab is not yet approved for use in the country.
Argentina's regulator on Wednesday approved the COVID-19 vaccine developed by AstraZeneca and Oxford University for emergency use, AstraZeneca said in a statement.
Brazil will soon weigh emergency-use approval for AstraZeneca's COVID-19 vaccine after Britain gave the green light on Wednesday, as Latin America's largest country rushes to catch up with immunization programs under way around the hard-hit region.
The COVID-19 vaccine developed by British drug maker AstraZeneca Plc and Oxford University will likely be authorized for emergency use in the United States in April, the chief adviser for the U.S. COVID-19 vaccine program said on Wednesday.
The European Medicines Authority (EMA) will most likely not be able to approve the COVID-19 vaccine developed by drug maker AstraZeneca and the University of Oxford in January, the watchdog’s Deputy Executive Director Noel Wathion said.